The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.80
Bid: 12.10
Ask: 13.00
Change: 0.80 (6.81%)
Spread: 0.90 (7.438%)
Open: 12.50
High: 12.50
Low: 11.80
Prev. Close: 11.75
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

9 Apr 2015 07:00

RNS Number : 6739J
Carclo plc
09 April 2015
 

For immediate release

9 April 2015

 

Carclo plc

("Carclo" or the "Group")

 

Year End Trading Update

 

The Board is pleased to announce that the Group has traded in line with its expectations for the financial year ended 31 March 2015.

 

Technical Plastics has benefitted from a strong last quarter and margins in this division continue to increase as high quality new programs are integrated in our global operations. Our capacity expansions in the US and Czech Republic are now complete and we expect our new facility in China will become fully operational during the new financial year. We have also started to increase capacity in India and at Tucson in the US with the securing of additional leased facilities. Overall these expansions will facilitate our continued growth in our key regions.

 

The LED Technologies division has also experienced a stronger second half at both Wipac and its LED Optics business. Wipac has continued to win additional supercar lighting programs and its recent capacity upgrade will facilitate the further growth we expect in this business.

 

Our Precision Engineering division has had a good year and we anticipate further moderate growth in this business in the new financial year.

 

Progress at Carclo Diagnostic Solutions has been encouraging with advances in microfluidics and plastics optimisation providing an increasingly strong underpinning for our Micropoc platforms. We have undertaken a third party commercialisation review which has resulted in an increased focus on the Troponin and CRP applications as these present the greatest commercially viable opportunities.

 

In October 2014, we announced that we had commenced a strategic review of our CIT Technology ("CIT") business. Over the last few months the Board has been considering all options for CIT ranging from our continued ownership through to a possible sale or licensing of the technology. To this end, we appointed corporate advisors to assist the Board in this process; to date we have seen some interest and discussions with potential acquirers remain ongoing. Regardless of the outcome of this, the Board intends that the Group will exit the CIT Touch and Printed Electronics businesses. CIT is still supporting last time purchases of product from its partner, Atmel Corporation, and will continue to manufacture coated film for approximately a further six months. This ongoing supply should not have any materially negative financial impact on the Group in the new financial year.

 

As previously announced, the Group's refinancing project is now complete and a new five year multi-currency revolving facility of £30.0 million has been agreed with HSBC.

 

The Board remains confident in the Group's strategy and is encouraged by the significant future growth prospects of its two main divisions. 

 

Carclo will announce its preliminary results for the year ended 31 March 2015 on 9 June 2015.

 

- ENDS -

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

N+1 Singer

Shaun Dobson

Richard Lindley

 

 

 

020 7496 3000

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

 

Notes to editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins the group has been investing in new technologies.

 

Approximately three fifths of revenues are currently derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSWFAAFISEIL
Date   Source Headline
30th Apr 20247:00 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.